Department of Infection Prevention and Control, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Department of Microbiology Laboratory, Tokyo Medical University Hospital, Tokyo, Japan.
BMC Infect Dis. 2021 Dec 5;21(1):1212. doi: 10.1186/s12879-021-06926-7.
Despite having a high mortality rate, Asian studies about the characteristics of adult listeriosis are limited. We investigated the incidence of listeriosis per admissions, associated factors, and rate of mortality in listeriosis, compared with non-listeriosis.
We recorded the incidence of listeriosis per 10,000 admissions and conducted a case-control study from January 1, 2010, to December 31, 2019, at Tokyo Medical University Hospital (TMUH) in Japan. Cases were defined as adult with listeriosis that was bacteremia due to L. monocytogenes. Controls, defined as adult with non-listeriosis bacteremia due to other pathogens, were matched by age and clinical department to cases. We analyzed differences in seasonality, including warm season (defined as the period from May to October), medication including steroids, laboratory findings, and mortality. The odds ratio and p value between the cases group and control group were calculated using a chi-square test and Fisher's exact test.
The incidence of listeriosis per 10,000 admissions to TMUH was 0.51. Eleven patients, excluding one neonate, were included in the case group. Twenty-six patients, excluding one patient because of contamination and one patient because of insufficient medical record, were included in the control group. Listeriosis onset was associated with the warm season (90.9% vs. 53.8%; p = 0.033), steroid use (54.5% vs. 19.2%; p = 0.042), and a lower ratio of neutrophils to lymphocytes (9.46 vs. 18.44; p = 0.015). The 30-day mortality rate of listeriosis was similar to non-listeriosis (18.3% vs. 19.2%; p = 0.619).
The incidence of listeriosis per admissions in this study was similar to that in other Asian countries. Factors associated with listeriosis were the warm season, steroid use, and a lower ratio of neutrophils to lymphocytes. Additionally, the 30-day mortality rate was similarly high in both the listeriosis and non-listeriosis groups.
尽管李斯特菌病的死亡率很高,但亚洲关于成人李斯特菌病特征的研究有限。我们调查了每 10000 例入院患者中李斯特菌病的发病率、相关因素以及李斯特菌病的死亡率,并与非李斯特菌病进行了比较。
我们记录了 2010 年 1 月 1 日至 2019 年 12 月 31 日期间,日本东京医科大学医院(TMUH)每 10000 例入院患者中李斯特菌病的发病率,并进行了病例对照研究。病例定义为因单核细胞增生李斯特菌引起的成人菌血症李斯特菌病。对照组定义为因其他病原体引起的成人菌血症但非李斯特菌病的患者,与病例按年龄和临床科室匹配。我们分析了季节性差异,包括温暖季节(定义为 5 月至 10 月期间)、包括类固醇在内的药物使用、实验室检查结果和死亡率。使用卡方检验和 Fisher 精确检验计算病例组和对照组之间的比值比和 p 值。
TMUH 每 10000 例入院患者中李斯特菌病的发病率为 0.51。11 名患者(不包括 1 名新生儿)被纳入病例组。26 名患者(不包括 1 名因污染和 1 名因病历不足而被排除的患者)被纳入对照组。李斯特菌病发病与温暖季节(90.9% vs. 53.8%;p = 0.033)、类固醇使用(54.5% vs. 19.2%;p = 0.042)和中性粒细胞与淋巴细胞比值较低(9.46 vs. 18.44;p = 0.015)相关。李斯特菌病 30 天死亡率与非李斯特菌病相似(18.3% vs. 19.2%;p = 0.619)。
本研究中每 10000 例入院患者中李斯特菌病的发病率与其他亚洲国家相似。与李斯特菌病相关的因素是温暖季节、类固醇使用和中性粒细胞与淋巴细胞比值较低。此外,李斯特菌病和非李斯特菌病组的 30 天死亡率相似。